Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster Diéthylcarbamazine (administration et posologie) - Filaricides (administration et posologie)

Terms

161Diéthylcarbamazine (administration et posologie)
148Filaricides (administration et posologie)
307Diéthylcarbamazine (usage thérapeutique)
563Filariose lymphatique (traitement médicamenteux)
297Filaricides (usage thérapeutique)
138Ivermectine (usage thérapeutique)
118Albendazole (usage thérapeutique)

Associations

Freq.WeightAssociation
900.583Diéthylcarbamazine (administration et posologie) - Filaricides (administration et posologie)
850.382Diéthylcarbamazine (administration et posologie) - Diéthylcarbamazine (usage thérapeutique)
2200.529Diéthylcarbamazine (usage thérapeutique) - Filariose lymphatique (traitement médicamenteux)
1570.520Diéthylcarbamazine (usage thérapeutique) - Filaricides (usage thérapeutique)
2120.518Filaricides (usage thérapeutique) - Filariose lymphatique (traitement médicamenteux)
1030.370Filariose lymphatique (traitement médicamenteux) - Ivermectine (usage thérapeutique)
930.361Albendazole (usage thérapeutique) - Filariose lymphatique (traitement médicamenteux)
980.340Filaricides (administration et posologie) - Filariose lymphatique (traitement médicamenteux)
1010.335Diéthylcarbamazine (administration et posologie) - Filariose lymphatique (traitement médicamenteux)

Documents par ordre de pertinence
003040 (2013) B. Nandha [Inde] ; K. Krishnamoorthy ; P. JambulingamTowards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.
007906 (2006) Marlieke E A. De Kraker [Pays-Bas] ; Wilma A. Stolk ; Gerrit J. Van Oortmarssen ; J Dik F. HabbemaModel-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti.
007955 (2006) I P Sunish [Inde] ; R. Rajendran ; T R Mani ; A. Munirathinam ; R. Reuben ; A P DashImpact of single dose of diethylcarbamazine and other antifilarial drug combinations on bancroftian filarial infection variables: assessment after 2 years.
008733 (2004) Report on the mid-term assessment of microfilaraemia reduction in sentinel sites of 13 countries of the Global Programme to Eliminate Lymphatic Filariasis.
008F56 (2003) Wilma A. Stolk [Pays-Bas] ; Subramanian Swaminathan [Inde] ; Gerrit J. Van Oortmarssen [Pays-Bas] ; P. K. Das [Inde] ; J. Dik F. Habbema [Pays-Bas]Prospects for Elimination of Bancroftian Filariasis by Mass Drug Treatment in Pondicherry, India: A Simulation Study
00A960 (1999) E A Ottesen [Suisse] ; M M Ismail ; J. HortonThe role of albendazole in programmes to eliminate lymphatic filariasis.
001237 (2016) Jean Frantz Lemoine [Haïti] ; Anne Marie Desormeaux [Haïti] ; Franck Monestime [Haïti] ; Carl Renad Fayette [Haïti] ; Luccene Desir [Haïti] ; Abdel Nasser Direny [États-Unis] ; Sarah Carciunoiu [États-Unis] ; Lior Miller [États-Unis] ; Alaine Knipes [États-Unis] ; Patrick Lammie [États-Unis] ; Penelope Smith [États-Unis] ; Melissa Stockton [États-Unis] ; Lily Trofimovich [États-Unis] ; Kalpana Bhandari [États-Unis] ; Richard Reithinger [États-Unis] ; Kathryn Crowley [États-Unis] ; Eric Ottesen [États-Unis] ; Margaret Baker [États-Unis]Controlling Neglected Tropical Diseases (NTDs) in Haiti: Implementation Strategies and Evidence of Their Success
001F26 (2015) I P Sunish [Inde] ; M. Kalimuthu [Inde] ; R. Rajendran [Inde] ; A. Munirathinam [Inde] ; V. Ashok Kumar [Inde] ; J. Nagaraj [Inde] ; B K Tyagi [Inde]Decline in lymphatic filariasis transmission with annual mass drug administration using DEC with and without albendazole over a 10year period in India.
002716 (2014) I P Sunish [Inde] ; A. Munirathinam [Inde] ; M. Kalimuthu [Inde] ; V. Ashok Kumar [Inde] ; B K Tyagi [Inde]Persistence of lymphatic filarial infection in the paediatric population of rural community, after six rounds of annual mass drug administrations.
003520 (2013) Khaled M. Abd Elaziz ; Maged El-Setouhy ; Mark H. Bradley ; Reda M. R. Ramzy ; Gary J. WeilKnowledge and Practice Related to Compliance with Mass Drug Administration during the Egyptian National Filariasis Elimination Program
004E22 (2011) Jonathan D. King [États-Unis] ; Emily Zielinski-Gutierrez ; Molisamoa Pa'Au ; Patrick LammieImproving community participation to eliminate lymphatic filariasis in American Samoa.
004F05 (2011) C N Wamae [Kenya] ; S M Njenga ; B M Ngugi ; J. Mbui ; H K NjaanakeEvaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.
005965 (2010) B G Ranganath [Inde]Coverage survey for assessing mass drug administration against lymphatic filariasis in Gulbarga district, Karnataka, India.
006195 (2009) Kapa D. RamaiahLymphatic filariasis elimination programme in India: progress and challenges.
007059 (2007) Shona Wynd [Royaume-Uni, Australie] ; Wayne D. Melrose [Australie] ; David N. Durrheim [Australie] ; Jaime Carron [Canada] ; Margaret Gyapong [Ghana]Understanding the community impact of lymphatic filariasis: a review of the sociocultural literature
007279 (2007) Caroline A. Grady [États-Unis] ; Madsen Beau De Rochars [Haïti] ; Abdel N. Direny [Haïti] ; Jean Nicolas Orelus [Haïti] ; Joyanna Wendt [États-Unis] ; Jeanne Radday [États-Unis] ; Els Mathieu [États-Unis] ; Jacquelin M. Roberts [États-Unis] ; Thomas G. Streit [États-Unis] ; David G. Addiss [États-Unis] ; Patrick J. Lammie [États-Unis]Endpoints for Lymphatic Filariasis Programs
007981 (2006) I P Sunish ; R. Rajendran ; T R Mani ; A P Dash ; B K TyagiEvidence for the use of albendazole for the elimination of lymphatic filariasis.
007E62 (2005) Madsen Beau De Rochars [Haïti] ; Sanjat Kanjilal ; Abdel N. Direny ; Jeanne Radday ; Jack G. Lafontant ; Els Mathieu ; Richard D. Rheingans ; Anne C. Haddix ; Thomas G. Streit ; Michael J. Beach ; David G. Addiss ; Patrick J. LammieThe Leogane, Haiti demonstration project: decreased microfilaremia and program costs after three years of mass drug administration.
007F87 (2005) Margaret Fraser [Vanuatu] ; George Taleo ; Fasihah Taleo ; James Yaviong ; Morris Amos ; Mark Babu ; Morris KalkoaEvaluation of the program to eliminate lymphatic filariasis in Vanuatu following two years of mass drug administration implementation: results and methodologic approach.
007F97 (2005) Wilma A. Stolk [Pays-Bas] ; Gerrit J. Van Oortmarssen ; S P Pani ; Sake J. De Vlas ; S. Subramanian ; P K Das ; J Dik F. HabbemaEffects of ivermectin and diethylcarbamazine on microfilariae and overall microfilaria production in bancroftian filariasis.
008693 (2004) S P Pani ; G Subramanyam Reddy ; P. Vanamail ; N. Venkatesvarlou ; L K Das ; A P VijayanTolerability and efficacy of single dose diethylcarbamazine (DEC) alone or co-administration with Ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, South India.
009412 (2002) Moses J. Bockarie [Papouasie-Nouvelle-Guinée] ; Daniel J. Tisch ; Will Kastens ; Neal D E. Alexander ; Zachary Dimber ; Florence Bockarie ; Ervin Ibam ; Michael P. Alpers ; James W. KazuraMass treatment to eliminate filariasis in Papua New Guinea.
00B206 (1998) Moses J. Bockarie [Papouasie-Nouvelle-Guinée] ; Neal De Alexander ; Philip Hyun [Papouasie-Nouvelle-Guinée] ; Zachary Dimber [Papouasie-Nouvelle-Guinée] ; Florence Bockarie [Papouasie-Nouvelle-Guinée] ; Ervin Ibam [Papouasie-Nouvelle-Guinée] ; Michael P. Alpers ; James W. Kazura [États-Unis]Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes
012898 (????) M J Bockarie ; E. Ibam ; N D Alexander ; P. Hyun ; Z. Dimber ; F. Bockarie ; M P Alpers ; J W KazuraTowards eliminating lymphatic filariasis in Papua New Guinea: impact of annual single-dose mass treatment on transmission of Wuchereria bancrofti in East Sepik Province.
001893 (2015) Christina A. Bulman [États-Unis] ; Chelsea M. Bidlow [États-Unis] ; Sara Lustigman [États-Unis] ; Fidelis Cho-Ngwa [Cameroun] ; David Williams [États-Unis] ; Alberto A. Rasc N Jr [États-Unis] ; Nancy Tricoche [États-Unis] ; Moses Samje [Cameroun] ; Aaron Bell [États-Unis] ; Brian Suzuki [États-Unis] ; K. C. Lim [États-Unis] ; Nonglak Supakorndej [États-Unis] ; Prasit Supakorndej [États-Unis] ; Alan R. Wolfe [États-Unis] ; Giselle M. Knudsen [États-Unis] ; Steven Chen [États-Unis] ; Chris Wilson [États-Unis] ; Kean-Hooi Ang [États-Unis] ; Michelle Arkin [États-Unis] ; Jiri Gut [États-Unis] ; Chris Franklin [États-Unis] ; Chris Marcellino [États-Unis] ; James H. Mckerrow [États-Unis] ; Anjan Debnath [États-Unis] ; Judy A. Sakanari [États-Unis]Repurposing Auranofin as a Lead Candidate for Treatment of Lymphatic Filariasis and Onchocerciasis
001E16 (2015) Tanaporn Toothong [Thaïlande] ; Mathuros Tipayamongkholgul [Thaïlande] ; Nawarat Suwannapong [Thaïlande] ; Saravudh Suvannadabba [Thaïlande]Evaluation of mass drug administration in the program to control imported lymphatic filariasis in Thailand
002099 (2015) Ram Kumar Adhikari [Oman] ; Jeevan Bahadur Sherchand ; Shiva Raj Mishra ; Kamal Ranabhat ; Rajendra Raj WagleAwareness and coverage of mass drug administration for elimination of lymphatic filariasis: a community based cross sectional study in Nepal.
002E61 (2014) Brittany A. Eddy ; Anna J. Blackstock ; John M. Williamson ; David G. Addiss ; Thomas G. Streit ; Valery M. Beau De Rochars ; Leanne M. FoxA Longitudinal Analysis of the Effect of Mass Drug Administration on Acute Inflammatory Episodes and Disease Progression in Lymphedema Patients in Léogane, Haiti
003041 (2013) Maria P. Rebollo [Royaume-Uni] ; Moses J. BockarieToward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame.
003751 (2013) Rabindra Nath Roy ; Aditya Prasad Sarkar ; Raghunath Misra ; Amitava Chakroborty ; Tusar Kanti Mondal ; Kanad BagCoverage and Awareness of and Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis in Burdwan District, West Bengal, India
005791 (2010) Mark J. Taylor [Royaume-Uni] ; Achim Hoerauf ; Moses BockarieLymphatic filariasis and onchocerciasis.
005843 (2010) A. Bhumiratana [Thaïlande] ; P. Pechgit ; S. Koyadun ; C. Siriaut ; P. YongyuthImported bancroftian filariasis: diethylcarbamazine response and benzimidazole susceptibility of Wuchereria bancrofti in dynamic cross-border migrant population targeted by the National Program to Eliminate Lymphatic Filariasis in South Thailand.
007240 (2007) K D Ramaiah [Inde] ; P K Das ; P. Vanamail ; S P PaniImpact of 10 years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis.
007914 (2006) K. Regu ; M K Showkath Ali ; R. Rajendran ; S M Koya ; B. Ganesh ; A C Dhariwal ; Shiv LalMass drug administration against lymphatic filariasis: experiences from Kozhikode district of Kerala State.
008048 (2005) Julia Critchley [Royaume-Uni] ; David Addiss ; Henry Ejere ; Carrol Gamble ; Paul Garner ; Hellen GelbandAlbendazole for the control and elimination of lymphatic filariasis: systematic review.
008049 (2005) Julia Critchley [Royaume-Uni] ; D. Addiss ; C. Gamble ; P. Garner ; H. Gelband ; H. EjereAlbendazole for lymphatic filariasis.
008054 (2005) B V Babu [Inde]A rapid method to assess the coverage of the mass drug administration of diethylcarbamazine in the program to eliminate lymphatic filariasis in India.
008869 (2004) David Addiss ; Julia Critchley ; Henry Ejere ; Paul Garner ; Hellen Gelband ; Carrol GambleAlbendazole for lymphatic filariasis.
008D83 (2003) K D Ramaiah [Inde] ; P K Das ; P. Vanamail ; S P PaniThe impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes.
009358 (2002) Reda M R. Ramzy [Égypte] ; Maged El-Setouhy ; Hanan Helmy ; Amr M. Kandil ; Ehab S. Ahmed ; Hoda A. Farid ; Rifky Faris ; Gary J. WeilThe impact of single-dose diethylcarbamazine treatment of bancroftian filariasis in a low-endemicity setting in Egypt.
009A39 (2001) Filariasis elimination, Zanzibar.
00A209 (2000) G. Dreyer [Brésil] ; J. Nor Es ; J. Figueredo-Silva ; W F PiessensPathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective.
00A285 (2000) J. Horton [Royaume-Uni] ; C. Witt ; E A Ottesen ; J K Lazdins ; D G Addiss ; K. Awadzi ; M J Beach ; V Y Belizario ; S K Dunyo ; M. Espinel ; J O Gyapong ; M. Hossain ; M M Ismail ; R L Jayakody ; P J Lammie ; W. Makunde ; D. Richard-Lenoble ; B. Selve ; R K Shenoy ; P E Simonsen ; C N Wamae ; M V WeerasooriyaAn analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
00A956 (1999) R K Shenoy [Inde] ; S. Dalia ; A. John ; T K Suma ; V. KumaraswamiTreatment of the microfilaraemia of asymptomatic brugian filariasis with single doses of ivermectin, diethylcarbamazine or albendazole, in various combinations.
00C258 (1995) P E Simonsen ; D W Meyrowitsch ; W H Makunde ; P. MagnussenSelective diethylcarbamazine chemotherapy for control of Bancroftian filariasis in two communities of Tanzania: compared efficacy of a standard dose treatment and two semi-annual single dose treatments.
00C299 (1995) P C Fan [République populaire de Chine] ; H W Peng ; C C ChenFollow-up investigations on clinical manifestations after filariasis eradication by diethylcarbamazine medicated common salt on Kinmen (Quemoy) Islands, Republic of China.
012E54 (????) B P Selve ; S. Bwadua ; M. Misa ; K. James ; J P Usurup ; P. Turner ; W. Melrose ; W. Yad ; R. Samuel ; C. EddieCommunity empowerment in the control of lymphatic filariasis in Misima, Milne Bay Province using diethylcarbamazine in combination with albendazole.
012F55 (????) Anil Kumar ; Pawan Sachan ; Ashis Bajpei ; Tejveer SinghA study to compare the effect of adding 12 days DEC regimen to 6 years annual mass drug administration to eliminate microfilaraemia infection in the community in rural Kanpur, Uttar Pradesh, India.
000A47 (2016) Denise Mupfasoni [Suisse] ; Antonio Montresor [Suisse] ; Alexei Mikhailov [Suisse] ; Jonathan King [Suisse]The Impact of Lymphatic Filariasis Mass Drug Administration Scaling Down on Soil-Transmitted Helminth Control in School-Age Children. Present Situation and Expected Impact from 2016 to 2020.
000C53 (2016) Inge Kroidl [Allemagne, Tanzanie] ; Elmar Saathof [Allemagne] ; Lucas Maganga [Tanzanie] ; Petra Clowes [Allemagne, Tanzanie] ; Leonard Maboko [Tanzanie] ; Achim Hoerauf [Allemagne] ; Williams H. Makunde [Tanzanie] ; Antelmo Haule [Tanzanie] ; Prisca Mviombo [Tanzanie] ; Bettina Pitter [Allemagne, Tanzanie] ; Neema Mgeni [Tanzanie] ; Joseph Mabuye [Tanzanie] ; Dickens Kowuor [Tanzanie] ; Upendo Mwingira [Tanzanie] ; Mwelecele N. Malecela [Tanzanie] ; Thomas Löscher [Allemagne] ; Michael Hoelscher [Allemagne, Tanzanie]Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania
000F79 (2016) Alison Krentel [Royaume-Uni] ; Rita Damayanti [Indonésie] ; Christiana Rialine Titaley [Indonésie] ; Nugroho Suharno [Indonésie] ; Mark Bradley [Royaume-Uni] ; Timothy Lynam [Australie]Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys.
001980 (2015) Gregory S. Noland ; Stephen Blount ; Manuel GonzalezPost-Mass Drug Administration Transmission Assessment Survey for Elimination of Lymphatic Filariasis in La Ciénaga, Dominican Republic
002845 (2014) Anil Kumar ; Pawan SachanMeasuring impact on filarial infection status in a community study: role of coverage of mass drug administration (MDA).
002E66 (2014) Ramakrishna U. Rao [États-Unis] ; Kumara C. Nagodavithana [Sri Lanka] ; Sandhya D. Samarasekera [Sri Lanka] ; Asha D. Wijegunawardana [Sri Lanka] ; Welmillage D. Y. Premakumara [Sri Lanka] ; Samudrika N. Perera [Sri Lanka] ; Sunil Settinayake [Sri Lanka] ; J. Phillip Miller [États-Unis] ; Gary J. Weil [États-Unis]A Comprehensive Assessment of Lymphatic Filariasis in Sri Lanka Six Years after Cessation of Mass Drug Administration
004B40 (2011) Francis Anto [Ghana] ; Victor Asoala ; Thomas Anyorigiya ; Abraham Oduro ; Martin Adjuik ; Patricia Akweongo ; Raymond Aborigo ; Langbong Bimi ; Joseph Amankwa ; Abraham HodgsonSimultaneous administration of praziquantel, ivermectin and albendazole, in a community in rural northern Ghana endemic for schistosomiasis, onchocerciasis and lymphatic filariasis.
004D04 (2011) Delynn M. Moss ; Jeffrey W. Priest ; Alexis Boyd ; Tiffany Weinkopff ; Zuzana Kucerova ; Michael J. Beach ; Patrick J. LammieMultiplex Bead Assay for Serum Samples from Children in Haiti Enrolled in a Drug Study for the Treatment of Lymphatic Filariasis
004D66 (2011) Cameron J. Jeremiah [Australie] ; Craig A. Aboltins ; Peter A. StanleyLymphatic filariasis in Australia: an update on presentation, diagnosis and treatment.
004E80 (2011) A. Hoerauf [Allemagne] ; K. Pfarr ; S. Mand ; A Y Debrah ; S. SpechtFilariasis in Africa--treatment challenges and prospects.
004F73 (2011) Ann S. Goldman ; Molly A. Brady ; Abdel Direny ; Luccene Desir ; Roland Oscard ; Jean-Francois Vely ; Mary Linehan ; Margaret BakerCosts of Integrated Mass Drug Administration for Neglected Tropical Diseases in Haiti
005790 (2010) A K Mukhopadhyay [Inde]Lymphatic filariasis in Andhra Pradesh Paper Mill Colony, Rajahmundry, India after nine rounds of MDA programme.
005925 (2010) Mohammad Sudomo [Indonésie] ; Sombat Chayabejara ; Socheat Duong ; Leda Hernandez ; Wei-Ping Wu ; Robert BergquistElimination of lymphatic filariasis in Southeast Asia.
005F93 (2009) J. Horton [Royaume-Uni]The development of albendazole for lymphatic filariasis.
006005 (2009) P J Hooper [États-Unis] ; M H Bradley ; G. Biswas ; E A OttesenThe Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007).
006265 (2009) K M Gustavsen [États-Unis] ; M H Bradley ; A L WrightGlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis.
006428 (2009) Yaya I. Coulibaly ; Benoit Dembele ; Abdallah A. Diallo ; Ettie M. Lipner ; Salif S. Doumbia ; Siaka Y. Coulibaly ; Siaka Konate ; Dapa A. Diallo ; Daniel Yalcouye ; Joseph Kubofcik ; Ogobara K. Doumbo ; Abdel K. Traore ; Adama D. Keita ; Michael P. Fay ; Sekou F. Traore ; Thomas B. Nutman ; Amy D. KlionA Randomized Trial of Doxycycline for Mansonella perstans Infection
006A62 (2008) A K Mukhopadhyay [Inde] ; S K Patnaik ; P. Satya Babu ; K N M B. RaoKnowledge on lymphatic filariasis and mass drug administration (MDA) programme in filaria endemic districts of Andhra Pradesh, India.
006B46 (2008) Taniawati Supali [Indonésie] ; Yenny Djuardi ; Kenneth M. Pfarr ; Heri Wibowo ; Mark J. Taylor ; Achim Hoerauf ; Jeanine J. Houwing-Duistermaat ; M. Yazdanbakhsh ; Erliyani SartonoDoxycycline treatment of Brugia malayi-infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatment.
007079 (2007) Maged El-Setouhy ; Khaled M. Abd Elaziz ; Hanan Helmy ; Hoda A. Farid ; Hussein A. Kamal ; Reda M. R. Ramzy ; William D. Shannon ; Gary J. WeilThe Effect of Compliance on the Impact of Mass Drug Administration for Elimination of Lymphatic Filariasis in Egypt
007112 (2007) B. Nandha [Inde] ; K. KrishnamoorthySchool-based health education campaign--a potential tool for social mobilization to promote the use of DEC-fortified salt towards elimination of lymphatic filariasis.
007239 (2007) G S A. Gunawardena [Sri Lanka] ; M M Ismail ; M H Bradley ; N D KarunaweeraImpact of the 2004 mass drug administration for the control of lymphatic filariasis, in urban and rural areas of the Western province of Sri Lanka.
007321 (2007) J A Rizzo [Brésil] ; C. Belo ; R. Lins ; G. DreyerChildren and adolescents infected with Wuchereria bancrofti in Greater Recife, Brazil: a randomized, year-long clinical trial of single treatments with diethylcarbamazine or diethylcarbamazine-albendazole.
007393 (2007) K. D. Ramaiah [Inde] ; P. Vanamail [Inde] ; P. K. Das [Inde]Changes in Wuchereria bancrofti infection in a highly endemic community following 10 rounds of mass administration of diethylcarbamazine
007983 (2006) David H. Molyneux [Royaume-Uni]Elimination of transmission of lymphatic filariasis in Egypt.
007A18 (2006) R. Rajendran [Inde] ; I P Sunish ; T R Mani ; A. Munirathinam ; N. Arunachalam ; K. Satyanarayana ; A P DashCommunity-based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India.
007A46 (2006) Shanmugavelu SabesanAlbendazole for mass drug administration to eliminate lymphatic filariasis.
007A47 (2006) B V Babu [Inde] ; K. Rath ; A S Kerketta ; B K Swain ; S. Mishra ; S K KarAdverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India.
007E41 (2005) Leanne M. Fox [États-Unis] ; Bruce W. Furness ; Jennifer K. Haser ; Jean-Marc Brissau ; Jacky Louis-Charles ; Susan F. Wilson ; David G. Addiss ; Patrick J. Lammie ; Michael J. BeachUltrasonographic examination of Haitian children with lymphatic filariasis: a longitudinal assessment in the context of antifilarial drug treatment.
007E47 (2005) S P Pani ; L K Das ; P. VanamailTolerability and efficacy of a three-age class dosage schedule of Diethylcarbamazine citrate (DEC) in the treatment of microfilaria carriers of Wuchereria bancrofti and its implications in mass drug administration (MDA) strategy for elimination of lymphatic filariasis (LF).
007F71 (2005) James MccarthyIs anthelmintic resistance a threat to the program to eliminate lymphatic filariasis?
008016 (2005) Prakash K. Sahoo [Inde] ; Ashok K. Satapathy ; Edwin Michael ; Balachandran RavindranConcomitant parasitism: bancroftian filariasis and intestinal helminths and response to albendazole.
008032 (2005) Adisak Bhumiratana [Thaïlande] ; Surachart Koyadun ; Mayuna Srisuphanunt ; Pratana Satitvipawee ; Nukool Limpairojn ; Gitipong GaewchaiyoBorder and imported bancroftian filariases: baseline seroprevalence in sentinel populations exposed to infections with Wuchereria bancrofti and concomitant HIV at the start of diethylcarbamazine mass treatment in Thailand.
008774 (2004) Peter Fischer [Allemagne] ; Taniawati Supali ; Rick M. MaizelsLymphatic filariasis and Brugia timori: prospects for elimination.
008818 (2004) Omar Hussein [Égypte] ; Maged El Setouhy ; Ehab S. Ahmed ; Amr M. Kandil ; Reda M R. Ramzy ; Hanan Helmy ; Gary J. WeilDuplex Doppler sonographic assessment of the effects of diethylcarbamazine and albendazole therapy on adult filarial worms and adjacent host tissues in Bancroftian filariasis.
008840 (2004) Madsen Beau De Rochars [Haïti] ; Abdel N. Direny ; Jacquelin M. Roberts ; David G. Addiss ; Jeanne Radday ; Michael J. Beach ; Thomas G. Streit ; Desire Dardith ; Jack Guy Lafontant ; Patrick J. LammieCommunity-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs.
008876 (2004) Maged El Setouhy [Égypte] ; Reda M R. Ramzy ; Ehab S. Ahmed ; Amr M. Kandil ; Omar Hussain ; Hoda A. Farid ; Hanan Helmy ; Gary J. WeilA randomized clinical trial comparing single- and multi-dose combination therapy with diethylcarbamazine and albendazole for treatment of bancroftian filariasis.
008E30 (2003) Malcolm DeanPacific nations lead the way in fighting lymphatic filariasis. Region aims to eliminate.
008E49 (2003) David H. Molyneux [Royaume-Uni] ; Mark Bradley ; Achim Hoerauf ; Dominique Kyelem ; Mark J. TaylorMass drug treatment for lymphatic filariasis and onchocerciasis.
008E94 (2003) Steven I. Mclaughlin [États-Unis] ; Jeanne Radday ; Marie Carmel Michel ; David G. Addiss ; Michael J. Beach ; Patrick J. Lammie ; John Lammie ; Richard Rheingans ; Jack LafontantFrequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000.
008F04 (2003) Achim Hoerauf [Allemagne] ; Sabine Mand ; Kerstin Fischer ; Thomas Kruppa ; Yeboah Marfo-Debrekyei ; Alexander Yaw Debrah ; Kenneth M. Pfarr ; Ohene Adjei ; Dietrich W. BüttnerDoxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production.
008F25 (2003) Wayne D. Melrose [Australie]Chemotherapy for lymphatic filariasis: progress but not perfection.
009346 (2002) Taniawati Supali [Indonésie] ; Is Suhariah Ismid ; Paul Rückert ; Peter FischerTreatment of Brugia timori and Wuchereria bancrofti infections in Indonesia using DEC or a combination of DEC and albendazole: adverse reactions and short-term effects on microfilariae.
009401 (2002) Dinesh C. SharmaNew goals set for filariasis elimination in India.
009417 (2002) Eric A. OttesenMajor progress toward eliminating lymphatic filariasis.
00AA14 (1999) L. Nicolas [Polynésie française] ; S. Langy ; C. Plichart ; X. DeparisFilarial antibody responses in Wuchereria bancrofti transmission area are related to parasitological but not clinical status.
00B747 (1997) E. A. Ottesen ; B. O. Duke ; M. Karam ; K. BehbehaniStrategies and tools for the control/elimination of lymphatic filariasis.
00B784 (1997) W C Cao [Pays-Bas] ; C P Van Der Ploeg ; A P Plaisier ; I J Van Der Sluijs ; J D HabbemaIvermectin for the chemotherapy of bancroftian filariasis: a meta-analysis of the effect of single treatment.
00BC51 (1996) J P Moulia-Pelat ; L N Nguyen ; H. Hascoet ; L. Nicolas[Combinations of ivermectin and diethylcarbamazine for improved control of lymphatic filariasis].
00CB91 (1993) H J Zheng [République populaire de Chine] ; Z H Tao ; W F Cheng ; S H Wang ; S Z Cheng ; Y M Ye ; L F Luo ; X R Chen ; G B Gan ; W F Piessens[Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine: immunological observation].
00CC22 (1993) V. NavaratnamRecent advances in the chemotherapy of lymphatic filariasis.
00CC74 (1993) J. Kazura [États-Unis] ; J. Greenberg ; R. Perry ; G. Weil ; K. Day ; M. AlpersComparison of single-dose diethylcarbamazine and ivermectin for treatment of bancroftian filariasis in Papua New Guinea.

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024